Clinical Impact of Metabolic Syndrome and Its Additive Effect With Smoking on Subsequent Cardiac Events After Acute Myocardial Infarction

American Journal of Cardiology

Volumn 99, Issue 7, 2007, Pages 885-889

  Nakatani, Daisaku ^a   Sakata, Yasuhiko ^a   Sato, Hiroshi ^a   Mizuno, Hiroya ^a   Shimizu, Masahiko ^a   Suna, Shinichiro ^a   Ito, Hiroshi ^b   Koretsune, Yukihiro ^c   Hirayama, Atsushi ^d   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sakurabashi Watanabe Hospital   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

^d OSAKA POLICE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SMOKING CESSATION;

AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; SURVIVAL ANALYSIS;

EID: 33947585534     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.11.033     Document Type: Article

References (12)

1. Kinjo K., Sato H., Ohnishi Y., Hishida E., Nakatani D., Mizuno H., Imai K., Nanto S., Naka M., and Matsumura Y. Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. Am J Cardiol 91 (2003) 931-935
2. Nakatani D., Sato H., Sakata Y., Shiotani I., Kinjo K., Mizuno H., Shimizu M., Ito H., Koretsune Y., Hirayama A., and Hori M. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 150 (2005) 652-658
3. NCEP Expert Panel. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
4. The Examination Committee of Criteria for "Obesity Disease" in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 66 (2002) 987-992
5. Malik S., Wong N.D., Franklin S.S., Kamath T.V., L'Italien G.J., Pio J.R., and Williams G.R. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110 (2004) 1245-1250
6. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., and Salonen J.T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
7. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., Taskinen M.R., and Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
8. Levantesi G., Macchia A., Marfisi R., Franzosi M.G., Maggioni A.P., Nicolosi G.L., Schweiger C., Tavazzi L., Tognoni G., Valagussa F., and Marchioli R. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 46 (2005) 277-283
9. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
10. Ishizaka N., Ishizaka Y., Toda E., Hashimoto H., Nagai R., and Yamakado M. Association between cigarette smoking, metabolic syndrome, and carotid arteriosclerosis in Japanese individuals. Atherosclerosis 181 (2005) 381-388
11. Facchini F.S., Hollenbeck C.B., Jeppesen J., Chen Y.D., and Reaven G.M. Insulin resistance and cigarette smoking. Lancet 339 (1992) 1128-1130
12. Targher G., Alberiche M., Zenere M.B., Bonadonna R.C., Muggeo M., and Bonora E. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82 (1997) 3619-3624